Repair and Regenerate ll

  • Overview of Repair and Regeneration

    • Axonal regeneration varies significantly between the peripheral nervous system (PNS) and central nervous system (CNS).
    • The goal in studying these differences is to find ways to promote recovery in the human brain and spinal cord after injuries or due to neurodegenerative diseases.

  • Differences in Axonal Regeneration

    • Peripheral Nervous System:
    • Robust axonal regeneration.
    • Ideal environment for neuronal growth with various supportive factors.
    • Central Nervous System:
    • Limited axonal regeneration, largely due to inhibitory factors.
    • The formation of a glial scar at the injury site, which hinders recovery.

  • Role of Glial Cells Post-Injury

    • Injury to the CNS activates all three types of glial cells: astrocytes, oligodendrocytes, and microglia.
    • Glial cells proliferate and form a glial scar, which can block axonal regrowth.
    • Reactive glial cells release inflammatory mediators that exacerbate tissue damage and discourage regrowth.

  • The Glial Scar

    • Acts as a mechanical barrier to axonal growth.
    • Contains growth-inhibitory molecules such as NOGO-A, MAG (Myelin-Associated Glycoprotein), and OMGP (Oligodendrocyte Myelin Glycoprotein).
    • The scar also leads to immune activation, increasing inflammation that further complicates recovery.

  • The Immune Response and Inflammation

    • Following CNS injury, the blood-brain barrier is compromised, allowing immune cells to invade and promote further inflammation.
    • Damage-associated molecular pattern (DAMP) molecules and cytokines are released, leading to more extensive immune responses and amplified injury.

  • Pathways Affecting Regeneration

    • Neuronal regeneration depends not only on the intrinsic ability of neurons to grow but also on the extracellular supportive environment.
    • Transplantation experiments show that peripheral nerve grafts can provide a favorable environment for central axon regeneration.

  • Therapeutic Strategies

    • Enhance the central environment with growth promoting agents, such as neurotrophins and scaffolds like laminin.
    • Chemical modifications or the removal of inhibitory signals from myelin or glial scars has been proposed as therapeutic avenues.
    • Chondroitinase treatment can breakdown CSPGs (Chondroitin Sulfate Proteoglycans) to promote regeneration.

  • Age and Growth Potential

    • Central axons exhibit reduced growth potential compared to peripheral ones, particularly as age increases.
    • Techniques like conditioning lesions, cyclic AMP injections, and GAP-43 applications help stimulate growth in damaged central axons.

  • Neurogenesis and Stem Cells

    • Neurogenesis continues into adulthood, particularly in the hippocampus and other specific regions.
    • Neural stem cells (NSCs) and induced pluripotent stem cells (iPSCs) offer potential for replacing lost neurons and repairing tissue.
    • iPSCs can be generated from patient-specific cells, thus avoiding rejection issues and allowing for genetic modification.

  • Implications for Disease and Recovery

    • Research into neurogenesis could improve recovery strategies for diseases like Parkinson’s and spinal cord injuries.
    • iPSCs have shown promise in differentiating into functional neurons that can integrate into existing circuits, offering hope for recovery after injury.

  • Functional Recovery without Regrowth

    • Post-injury functional recovery is possible even without axonal regeneration due to neural plasticity and compensatory changes in neural circuits.
    • Rehabilitation and training can promote rewiring in neural circuits, enhancing recovery of motor functions.

  • Recent Advances

    • Combining neural stem cell therapy with rehabilitation strategies is being explored to enhance overall recovery in injured individuals.
    • Development of novel approaches using electrochemical neural prosthetics for improving motor function post-injury.

  • Future Directions

    • Ongoing research aims to close the gap in regenerative capability between the PNS and CNS, aiming for breakthroughs in therapeutic interventions and functional recovery post-injury.
    • The integration of engineering advances and biological therapies hold the potential to revolutionize recovery from CNS injuries.